Science

AddToAny

Google+ Facebook Twitter Twitter

Crimean-Congo haemorrhagic fever

Dr Arantza Portillo discusses the changing epidemiology of this tick-borne viral disease in Spain and looks at the future situation for the UK.

Crimean-Congo haemorrhagic fever (CCHF), which is caused by the virus with the same name (CCHFV), is the tick-borne arboviruses most widely distributed in the world. The disease can also be acquired in the work environment through contact with infected animals (slaughterhouse workers or butchers) or with secretions from infected patients (hospital-acquired infections), as happened in Spain some years ago. Vertical transmission and sexual transmission have been also documented.

For a number of reasons, such as a better knowledge of the disease by healthcare workers, the availability of diagnostic techniques and (probably) due to an increase in the distribution and number of its vectors, the incidence of CCHF has increased in recent years. Due to its epidemic potential, it is one of the diseases that the World Health Organization has prioritised for research and development for years, and it continues to be included in the new update.

Click here to read the full article.

Image credit | Science-Photo-Library | Cretav Laboratory

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top